New and illicit drugs keep flooding the market in the United States and they keep finding their way to people who are sometimes oblivious to their effects. Law enforcement agencies try their best to keep such drugs off the streets, but drug traffickers often devise new ways to bend the rules.
At times, existing and already available drugs are relabeled, repackaged and mixed with other potent substances and are made available in the market that are not recognized by gullible buyers. There are many such synthetic drugs that toxicologists and law enforcement agencies try to keep a tab of and take necessary steps to save people’s lives. One such synthetic opioid, called Pink, was temporarily banned by the Drug Enforcement Administration (DEA) in November 2016 after it took lives of 46 people. Very little is known about this drug and how it found its way to unsuspecting victims.
Pink was developed in mid-1970s
The classified name of pink is U-47700 and it was derived from morphine. It was created by a chemist named Jacob Szmuszkovicz who worked in Upjohn Company, a chemical company in Michigan. The first letter of the drug U was taken from Upjohn. The drug is about eight times stronger than its distant cousin morphine and an extremely potent compound, similar to other synthetic opioids and fentanyl. The Food and Drug Administration (FDA) never approved its human use.
Law enforcement agencies in Ohio had seized 500 blue pills that were initially thought to be short-acting oxycodone pills, but after a laboratory analysis of the substance, it was confirmed that they were U-47700. The drug is a chalky white powder that is also available in liquid form in dropper bottles and as nasal inhalers. Also known as “pink,” “pinky” or “pinkie,” the names are not in any way a reference to its color. The name originates from the act of sticking out the pinky finger and taking the drug through the nostrils, a process narcotic users are quite familiar with.
DEA categorized Pink as Schedule I substance
According to reports received by the DEA between October 2015 and September 2016, of the 46 known fatalities due to the use of Pink, 31 deaths occurred in New York, while 10 were in North Carolina. The DEA had classified Pink as a Schedule I substance, a dangerously addictive drug like heroin and LSD that does not have any medicinal value. This scheduling will last for the next two years with the possibility of extension, depending on the necessary data required to determine if it could be permanently scheduled.
Path to recovery
Little is known about how U-47700 works on the brain apart from the fact that it is an opioid and can cause respiratory depression. The drug can cause a sense of exhilaration along with numbness and sedateness. Naloxone has been successful in mitigating and blocking the effects of the drug. After looking at the history of the drug use in the fatal overdose cases, the DEA said that the people likely to abuse U-47700 are those who abuse prescription opioid analgesics.
If you or a loved one is showing signs of prescription abuse, it is imperative to seek professional help. Contact the Prescription Drug Abuse Helpline to connect to the best prescription drug abuse treatment clinic in USA. Call at our 24/7 helpline number 866-450-1557 or chat online with our medical advisors to locate the best prescription drug abuse treatment centers in USA.